<unk> , sold under the brand name Cimzia, is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB. It is on the World Health Organization's List of Essential Medicines.
Certolizumab pegol
Mepolizumab
Vedolizumab
Belatacept
Natalizumab
Satralizumab
Emicizumab
Nemolizumab